Alvotech
NASDAQ: ALVOW0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Market
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Lisa Graver
- Employees
- 1,012
- Headquarters
- Luxembourg, Iceland
- IPO year
- 2022
- Market cap
- $1.3B
- Website
- https://www.alvotech.com
Loading ALVOW…
Loading profile data…Frequently asked questions about ALVOW
What does Alvotech (ALVOW) do?
Alvotech Holdings SA is an Icelandic enterprise that, operating via its subsidiary companies, undertakes the development and fabrication of biosimilar pharmaceuticals destined for international consumption.
Where does ALVOW trade?
Alvotech (ALVOW) trades on the NASDAQ Global Market.
What sector is ALVOW in?
Alvotech (ALVOW) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Alvotech?
Lisa Graver is the chief executive officer of Alvotech (ALVOW).
Where is Alvotech headquartered?
Alvotech is headquartered in Iceland.
Does ALVOW pay a dividend?
Alvotech (ALVOW) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did ALVOW go public?
Alvotech (ALVOW) completed its initial public offering in 2022.